For past Congresses, use the Browse menu.
SRES 510
118th Congress • 2023–2025 (Ended)

A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.


Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…